RadNet completes acquisition of Image Medical

NewsGuard 100/100 Score

RadNet, Inc. (Nasdaq:RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully-owned and operated outpatient imaging centers, today reported it has completed the previously announced acquisition of Image Medical Corporation, parent of eRAD, Inc.

In September 2010, the Company executed a definitive purchase agreement to acquire Image Medical Corporation, the parent of eRAD, Inc., for $10.75 million in a combination of cash and promissory notes. eRAD, Inc., headquartered in Greenville, South Carolina, has been a premier provider of Picture Archiving and Communications Systems (PACS) and related workflow solutions to the radiology industry since 1999. Over 250 hospitals, teleradiology businesses, imaging centers and specialty physician groups use eRAD's technology to distribute, visualize, store and retrieve digital images taken from all diagnostic imaging modalities.

"We are pleased to welcome the many outstanding employees of eRAD into the RadNet organization. We are very excited about adding eRAD's solutions and capabilities to our operation. Furthermore, we remain focused on continuing eRAD's tradition of providing innovative products to its many existing customers and to the imaging industry at large," said Dr. Howard Berger, President and Chief Executive Officer of RadNet.

Source:

 RadNet, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New blood test shows promise in early detection of ovarian cancer